Oncology surgeons at Brigham and Women’s Hospital (BWH) are among the world’s leading specialists in management of sarcomas, providing expert diagnosis and treatment of these rare and complicated malignancies. Our board certified oncology surgeons have advanced training in oncology surgery and are faculty members at Harvard Medical School. They are also training the next generation of surgeons through the Dana-Farber/Partners Cancer Care Surgical Oncology Fellowship program.
Our Sarcoma Services team helps sarcoma patients get better faster - with improved outcomes and fewer post-operative problems - by following evidence-based techniques, many of which were developed at BWH. They are also active in medical research with goals including the development of more effective treatment strategies for both soft tissue and bone sarcomas.
Sarcomas are cancerous (malignant) tumors of the connective tissues of the body: fat, blood vessels, nerves, bones, muscles, muscles, cartilage and deep skin tissue. Although rare, there are approximately 14,000 new cases of sarcoma diagnosed each year in the United States.
There are more than 50 types of sarcoma which are grouped into two main types: soft tissue sarcoma and bone sarcoma, or osteosarcoma. About one out of 100 cases of adult cancers is a soft tissue sarcoma. Osteosarcomas are even rarer. Sarcomas can be treated, usually by having surgery to remove the tumor.